References
- Solarczyk, P., Majewska, A.C. (2010). A survey of the prevalence and genotypes of Giardia duodenalis infecting household and sheltered dogs. Parasitol Res. 106(5): 1015-1019. https://doi.org/10.1007/s00436-010-1766-5 PMid:20155370
- Boucard, A.S., Thomas, M., Lebon, W., Polack, B., Florent, I., Langella, P., Bermudez-Humaran, L.G. (2021). Age and Giardia intestinalis infection impact canine gut microbiota. Microorganisms. 9(9): 1862. https://doi.org/10.3390/microorganisms9091862 PMid:34576757 PMCid:PMC8469385
- Einarsson, E., Ma’ayeh, S., Svard, S.G. (2016). An update on Giardia and giardiasis. Curr Opin Microbiol. 34, 47-52. https://doi.org/10.1016/j.mib.2016.07.019 PMid:27501461
- Ballweber, L.R., Xiao, L.H., Bowman, D.D., Kahn, G., Cama, V.A. (2010). Giardiasis in dogs and cats: update on epidemiology and public health significance. Trends Parasitol. 26(4): 180-189. https://doi.org/10.1016/j.pt.2010.02.005 PMid:20202906
- Ortega-Pierres, M.G., Jex, A.R., Ansell, B.R.E., Svard, S.G. (2018). Recent advances in the genomic and molecular biology of Giardia. Acta Trop. 184, 67-72. https://doi.org/10.1016/j.actatropica.2017.09.004 PMid:28888474
- Adam, R.D. (2021). Giardia duodenalis: biology and pathogenesis. Clin Microbiol Rev. 34(4): e00024-19. https://doi.org/10.1128/CMR.00024-19 PMid:34378955 PMCid:PMC8404698
- Cotton, J.A., Beatty, J.K., Buret, A.G. (2011). Host-parasite interactions and pathophysiology in Giardia infections. Int J Parasitol. 41(9): 925-933. https://doi.org/10.1016/j.ijpara.2011.05.002 PMid:21683702
- Dixon, B.R. (2021). Giardia duodenalis in humans and animals - Transmission and disease. Res Vet Sci. 135, 283-289. https://doi.org/10.1016/j.rvsc.2020.09.034 PMid:33066992
- Thompson, R.C.A., Palmer, C.S., O’Handley, R. (2008). The public health and clinical significance of Giardia and Cryptosporidium in domestic animals. Vet J. 177(1): 18-25. https://doi.org/10.1016/j.tvjl.2007.09.022 PMid:18032076 PMCid:PMC7128580
- Yildiz, I.K., Ok, M. (2022). Investigation of biomarkers indicating intestinal damage in Isospora-infected dogs. Hungar Vet J. 144(2): 101-113. [In Hungarian]
- Yildiz, R., Ok, M., Ider, M., Akar, A., Naseri, A., Koral, E. (2019). The changes in biomarkers for necrotising enterocolitis in premature calves with respiratory distress syndrome. Vet Med. 64(10): 440-447. https://doi.org/10.17221/37/2019-VETMED
- Yildiz, R., Ok, M., Ider, M., Aydin, U., Naseri, A., Parlak, K., Gulersoy, E. (2018). Evaluation of intestinal damage biomarkers in calves with atresia coli. J Vet Res. 62(3): 379-384. https://doi.org/10.2478/jvetres-2018-0054 PMid:30584620 PMCid:PMC6295999
- Gulersoy, E., Ok, M., Yildiz, R., Koral, E., Ider, M., Sevinc, M., Zhunushova, A. (2020). Assessment of intestinal and cardiac-related biomarkers in dogs with parvoviral enteritis. Pol J Vet Sci. 23(2): 211-219. https://doi.org/10.24425/pjvs.2020.133635 PMid:32627989
- Ok, M., Yildiz, R., Hatipoglu, F., Baspinar, N., Ider, M., Uney, K., Erturk, A., Durgut, M.K., Terzi, F. (2020). Use of intestine-related biomarkers for detecting intestinal epithelial damage in neonatal calves with diarrhea. Am J Vet Res. 81(2): 139-146. https://doi.org/10.2460/ajvr.81.2.139 PMid:31985285
- Durgut, M.K., Ok, M. (2023). Evaluation of some intestinal biomarkers in the deter mination of intestinal damage in calves with coccidiosis. Trop Anim Sci J. 46(2): 221-230. https://doi.org/10.5398/tasj.2023.46.2.221
- Ekici, Y.E., Ok, M. (2024). Investigation of the relationship between atopic dermatitis of dogs and intestinal epithelial damage. Vet Med Sci. 10(3): e1453. https://doi.org/10.1002/vms3.1453 PMid:38648253 PMCid:PMC11034634
- Foreyt, W.J. (2013). Veterinary parasitology reference manual. John Wiley & Sons
- Coe, N.R., Bernlohr, D.A. (1998). Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta. 1391(3): 287-306. https://doi.org/10.1016/S0005-2760(97)00205-1
- Guzman-Guzman, I.P., Nogueda-Tor res, B., Zaragoza-Garcia, O., Navarro-Zarza, J.E., Briceno, O., Perez-Rubio, G., Falfan-Valencia, R., et al. (2022). The infection, coinfection, and abundance of intestinal protozoa increase the serum levels of IFABP2 and TNF-α in patients with rheumatoid arthritis. Front Med. 9, 846934. https://doi.org/10.3389/fmed.2022.846934 PMid:35492365 PMCid:PMC9039364
- Ludwig, E.K., Hobbs, K.J., McKinney-Aguirre, C.A., Gonzalez, L.M. (2023). Biomarkers of intestinal injury in colic. Animals (Basel). 13(2): 227. https://doi.org/10.3390/ani13020227 PMid:36670767 PMCid:PMC9854801
- Sarikaya, M., Ergul, B., Dogan, Z., Filik, L., Can, M., Arslan, L. (2015). Intestinal fatty acid binding protein (I-FABP) as a promising test for Crohn’s disease: A preliminary study. Clin Lab. 61(1-2): 87-91. https://doi.org/10.7754/Clin.Lab.2014.140518 PMid:25807642
- Oldenburger, I.B., Wolters, V.M., Kardol-Hoefnagel, T., Houwen, R.H.J., Otten, H.G. (2018). Serum intestinal fatty acid-binding protein in the noninvasive diagnosis of celiac disease. APMIS 126(3): 186-190. https://doi.org/10.1111/apm.12800 PMid:29383769
- Cascais-Figueiredo, T., Austriaco-Teixeira, P., Fantinatti, M., Silva-Freitas, M.L., Santos-Oliveira, J.R., Coelho, C.H., Singer, S.M., Da-Cruz, A.M. (2020). Giardiasis alters intestinal fatty acid binding protein (I-FABP) and plasma cytokine levels in children in Brazil. Pathogens. 9(1): 7. https://doi.org/10.3390/pathogens9010007 PMid:31861618 PMCid:PMC7169386
- Straarup, D., Gotschalck, K.A., Christensen, P.A., Krarup, H., Lundbye-Christensen, S., Handberg, A., Thorlacius-Ussing, O. (2023). Exploring I-FABP, endothelin-1 and L-lactate as biomarkers of acute intestinal necrosis: a case-control study. Scand J Gastroenterol. 58(12): 1359-1365. https://doi.org/10.1080/00365521.2023.2229930 PMid:37403410
- Ay, C.D., Tuna, G.E., Asici, G.S.E., Ulutas, B., Voyvoda, H. (2022). Serum intestinal fatty acid-binding protein and calprotectin concentrations to assess clinical severity and prognosis of canine parvovirus enteritis. Kafkas Univ Vet Fak Derg. 28(1): 105-114.
- Goldberg, R.F., Austen, W.G., Zhang, X.B., Munene, G., Mostafa, G., Biswas, S., McCormack, M., et al. (2008). Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci U.S.A. 105(9): 3551-3556. https://doi.org/10.1073/pnas.0712140105 PMid:18292227 PMCid:PMC2265168
- Kuhn, F., Adiliaghdam, F., Cavallaro, P.M., Hamarneh, S.R., Tsurumi, A., Hoda, R.S., Munoz, A.R., et al. (2020). Intestinal alkaline phosphatase targets the gut barrier to prevent aging. JCI Insight. 5(6): 134049. https://doi.org/10.1172/jci.insight.134049 PMid:32213701 PMCid:PMC7213802
- Martins, R.D.S., Kooi, E.M.W., Poelstra, K., Hulscher, J.B.F. (2023). The role of intestinal alkaline phosphatase in the development of necrotizing enterocolitis. Early Hum Dev. 183, 105797. https://doi.org/10.1016/j.earlhumdev.2023.105797 PMid:37300991
- Rentea, R.M., Liedel, J.L., Fredrich, K., Pritchard, K.T. Jr., Oldham, K.T., Simpson, P.M., Gourlay, D.M. (2013). Enteral intestinal alkaline phosphatase administration in newbor ns decreases iNOS expression in a neonatal necrotizing enterocolitis rat model. J Pediatr Surg. 48(1): 124-128. https://doi.org/10.1016/j.jpedsurg.2012.10.026 PMid:23331804 PMCid:PMC5664149
- Biesterveld, B.E., Koehler, S.M., Heinzerling, N.P., Rentea, R.M., Fredrich, K., Welak, S.R., Gourlay, D.M. (2015). Intestinal alkaline phosphatase to treat necrotizing enterocolitis. J Surg Res. 196(2): 235-240. https://doi.org/10.1016/j.jss.2015.02.030 PMid:25840489 PMCid:PMC4578817
- Molnar, K., Vannay, A., Szebeni, B., Banki, N.F., Sziksz, E., Cseh, A., Gyorffy, H., et al. (2012). Intestinal alkaline phosphatase in the colonic mucosa of children with inf lammatory bowel disease. World J Gastroenterol. 18(25): 3254-3259.
- Park, S.Y., Kim, J.Y., Lee, S.M., Chung, J.O., Seo, J.H., Kim, S., Kim, D.H., et al. (2018). Lower expression of endogenous intestinal alkaline phosphatase may predict worse prognosis in patients with Crohn’s disease. BMC Gastroenterol. 18(1): 188. https://doi.org/10.1186/s12876-018-0904-x PMid:30558547 PMCid:PMC6296121
- Thim, L. (1994). Trefoil peptides: a new family of gastrointestinal molecules. Digestion. 55(6): 353-360. https://doi.org/10.1159/000201165 PMid:7705547
- Ng, E.W.Y., Poon, T.C.W., Lam, H.S., Cheung, H.M., Ma, T.P.Y., Chan, K.Y.Y., Wong, R.P.O., et al. (2013). Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann Surg. 258(6): 1111-1118. https://doi.org/10.1097/SLA.0b013e318288ea96 PMid:23470582
- Srivastava, S., Kedia, S., Kumar, S., Mouli, V.P., Dhingra, R., Sachdev, V., Tiwari, V., et al. (2015). Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity. J Crohns Colitis. 9(7): 575-579. https://doi.org/10.1093/ecco-jcc/jjv075 PMid:25964429